Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Cheng Du Sheng Nuo Biotec Co., Ltd. on 6ix
Earlier from Cheng Du Sheng Nuo Biotec
- Announcement on Progress in Major Daily Operation Contracts of Wholly-owned Subsidiary
- Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
- Announcement on Shareholding Reduction Results for Shareholders Holding Over 5% Shares, Partial Directors and Senior Management Members
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares to Below 5% and Reaching 1% Scale
- Announcement on Voluntary Disclosure of Pentapeptide-18 Passing the New Cosmetic Ingredient Registration
Later from Cheng Du Sheng Nuo Biotec
- Announcement on Voluntary Disclosure of Proposed Selection Results of Participating in National Organized Bulk Purchasing of Drugs for Successive Procurements
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of Notice on Listing Application Approval for Liraglutide Drug Substance
- Announcement on Shareholding Reduction Result and Non-Execution of Shareholding Reduction by Some Directors and Senior Management Members
- Announcement on Voluntary Disclosure of Obtaining Drug Production License by Wholly-owned Subsidiary
Follow Cheng Du Sheng Nuo Biotec into a list and get an email when it puts out news.
Follow Cheng Du Sheng Nuo Biotec